Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Private Equity Firm
Manufacturing
Performance Cell bought by private equity firm, rebrands itself
Performance Cell Manufacturing was bought by Great Point Partners for an undisclosed price and has been rebranded to Cellipont Bioservices.
Joseph Keenan
Jan 12, 2022 10:05am
AZ reportedly blocked buyout of rare disease specialist Sobi
Dec 3, 2021 10:25am
GSK's consumer health unit draws buyout interest amid spinoff
Oct 12, 2021 11:13am
French API maker Seqens primed for sale to the tune of $2.4B
Feb 10, 2021 7:30am
PCI Pharma offloads majority stake in expansion play abroad
Aug 25, 2020 9:45am
Takeda to sell Japan OTC unit to Blackstone: reports
Aug 19, 2020 9:45am